- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Thought insertion.
Displaying page 1 of 1.
| EudraCT Number: 2012-005653-22 | Sponsor Protocol Number: NL13PAR | Start Date*: 2014-08-25 |
| Sponsor Name:Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital [...] | ||
| Full Title: TachoSil patch application as replacement of closed suction wound drainage by parotid gland surgery; a prospective study. | ||
| Medical condition: The surgical procedure of parotidectomy whereby a protid tumor is removed. During this procedure the wound surface will be covered by the surgical sealing patch TachoSil instead of the use of a c... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-002883-27 | Sponsor Protocol Number: NAA104606 | Start Date*: 2005-10-06 |
| Sponsor Name:GlaxoSmithKline Research and Development Limited | ||
| Full Title: A multi-centre, double blind, double-dummy, placebo-controlled, randomised, adaptive, dose-range study to evaluate the dafety and efficacy of SB-773812 administered once daily for 12 weeks in adult... | ||
| Medical condition: Schizophrenia | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: CZ (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2018-002077-21 | Sponsor Protocol Number: ICR-CTSU/2017/10065 | Start Date*: 2019-04-18 | |||||||||||
| Sponsor Name:The Institute of Cancer Research | |||||||||||||
| Full Title: PHOENIX Trial: A pre-surgical window of opportunity and post-surgical adjuvant biomarker study of DNA damage response inhibition and/or anti-PD-L1 immunotherapy in patients with neoadjuvant chemoth... | |||||||||||||
| Medical condition: Triple Negative Breast Cancer | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2004-002181-38 | Sponsor Protocol Number: WARCEF | Start Date*: 2004-10-22 |
| Sponsor Name:NIH-National Institut of Health - NINDS-National Institut of Neurogical Disorders and Stroke | ||
| Full Title: Warfarin versus Aspirin in Reduced Ejection Fraction. | ||
| Medical condition: Patients with left ventricular disfunction with ejection fraction less or equal to 35%. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: HU (Completed) SK (Completed) GB (Completed) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.